Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology International"
DOI: 10.1007/s00296-018-4022-4
Abstract: The utility of monitoring drug levels in rheumatoid arthritis and spondyloarthritis patients on biological therapy is called into question. The objective was to study relevant clinical questions on the topic, i.e., (1) whether drug levels… read more here.
Keywords: drug; arthritis spondyloarthritis; rheumatoid arthritis; drug levels ... See more keywords
Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.
Sign Up to like & getrecommendations! Published in 2018 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000516
Abstract: Purpose of review The present review presents an overview of the evolution in trial design from mainly randomized placebo-controlled efficacy trials to more strategic clinical trials in rheumatoid arthritis and spondyloarthritis. Additionally, it relates to… read more here.
Keywords: arthritis spondyloarthritis; clinical trials; trials rheumatoid; rheumatoid arthritis ... See more keywords
Adverse reaction profile of sulfasalazine and its persistence in chronic therapy of rheumatoid arthritis and spondyloarthritis: A multicentric observational study.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp204120
Abstract: OBJECTIVES Sulfasalazine has been widely used in treatment of rheumatoid arthritis and spondyloarthritis. This study aims to assess persistence with sulfasalazine and also frequency and severity of adverse drug reactions (ADRs) encountered with this very… read more here.
Keywords: arthritis spondyloarthritis; sulfasalazine; rheumatoid arthritis; drug ... See more keywords